The opinion of the court was delivered by: Hon. Harold Baer, Jr., District Judge:
Before the Court is a partial motion to dismiss brought by defendants Unigene Laboratories, Inc. and Unigene Patent Properties Nos. 1 through 120 (collectively, "Defendants" or "Unigene"). The complaint filed by plaintiff Ostrolenk Faber LLP ("Plaintiff" or "Ostrolenk") asserts claims for breach of contract, account stated, quantum meruit, and unjust enrichment. Compl. ¶¶ 22-44. By its motion, Unigene seeks dismissal of the claim for breach of contract, or in the alternative, a more definite statement under Federal Rule of Civil Procedure ("FRCP") 12(e), and seeks dismissal of Ostrolenk's demand for attorneys' fees. For the reasons set forth below, the motion to dismiss is GRANTED.
Ostrolenk is a New York-based law firm that specializes in intellectual property ("IP") services. Compl. ¶¶ 1, 7. Unigene is a pharmaceutical company that is incorporated in Delaware and has its principal place of business in New Jersey. Id. ¶¶ 2, 8. Between October 1984 and July 2011, Ostrolenk provided IP-related legal services-including the filing of over 120 patents-to Unigene. Id. ¶ 16; see Compl. Ex. 1. Over the course of more than 25 years, the Complaint alleges that Unigene retained Ostrolenk to provide legal services, Compl. ¶¶ 9, 16, and Ostrolenk "advanced and expended substantial sums of its own money for disbursements to cover patent office filing fees and charges by foreign law offices." Id. at ¶ 11. Ostrolenk then provided detailed monthly invoices to Unigene that specified, among other things, a description of the services rendered, the hours worked, the names of the attorneys who performed the work, the attorneys' respective hourly rates, the fees incurred (such as the patent filing fees), and other disbursements. See Compl. Ex. 2. Until February 2011, Unigene "promptly" paid Ostrolenk the full amount of each invoice. Compl. ¶ 16. In July 2011, Unigene terminated Ostrolenk as its IP legal service provider. Id. ¶ 18. As of the filing of Ostrolenk's complaint, the total amount in unpaid invoices equaled $402,388.66. Id. ¶ 19. This amount comprises $231,508.50 for legal services and $170,880.16 for outstanding disbursements. Id.
By this motion, Unigene seeks to dismiss the breach of contract claim pursuant to FRCP 12(b)(6) or, in the alternative, moves for a more definite statement of Ostrolenk's breach of contract claim pursuant to FRCP 12(e). Unigene asserts that Ostrolenk "failed to plead the material terms of the contract, failed to attach any agreement, and failed to identify the specific provisions of the. . . agreement implicated in this action." MTD 7. The motion also seeks to dismiss Ostrolenk's claim for attorneys' fees, costs and disbursements "incurred in connection with the litigation of the claims in this Complaint," Compl., Ad Damnum Clause E, arguing that "as a matter of law, the Law Firm is not entitled to an award of attorneys' fees." MTD 8.
According to the Supreme Court's most recent pronouncements, "[t]o survive a motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to 'state a claim to relief that is plausible on its face.' " Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007)). "A claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged." Id. (citing Twombly, 550 U.S. at 556). The requirement that the court accept all factual allegations as true does not apply to "[t]hreadbare recitals of the elements of a cause of action, supported by mere conclusory statements." Id. The court's determination of whether a complaint states a "plausible claim for relief" is a "context-specific task" that requires application of "judicial experience and common sense." Id. at 679.
B. The Claim for Breach of Contract is Dismissed
"Under New York law, the elements of a breach of contract claim are
the formation of an agreement, performance by one party, breach of the
agreement by the other party, and damages." Berman v. Sugo LLC, 580 F.
Supp. 2d 191, 202 (S.D.N.Y. 2008) (citing First Investors Corp. v.
Liberty Mut. Ins. Co., 152 F.3d 162, 168 (2d Cir. 1998)).*fn1
Each of the elements need not be pleaded individually, but a
claim that fails "to allege facts sufficient to show that an
enforceable contract existed" is subject to dismissal. Banco Esprito
Santo de Investimento, S.A. v. Citibank, N.A., No. 03 Civ. 1537, 2003
WL 23018888, at *4--5 (S.D.N.Y. Dec. 22, 2003) (dismissing breach of
contract claim where there were insufficient facts to support the
formation of an oral contract and where repeated disclaimers stated
that the parties would be bound only by the provisions of a final,
written agreement) (cited in Berman, 580 F. Supp. 2d at 202).
Although the Complaint alleges that Unigene "agreed to pay Ostrolenk for services provided," referring to this as the "Agreement," Compl. ¶ 12, Ostrolenk fails to offer any allegations about the terms of the Agreement, whether it was oral or written, express or implied. See Berman, 580 F. Supp. at 202 (explaining that the counterclaims sounding in breach of contract failed to allege whether the contract was oral and that "[d]efendants are entitled to this information since in the absence thereof [they] cannot know whether to plead affirmative defenses based on . . . [the] statute of frauds") (internal quotation marks and citation omitted); Posner v. Minnesota Mining & Mfg. Co., 713 F. Supp. 562, 563 (E.D.N.Y.1989) ("Although the existence of a contract is alleged, plaintiffs fail to set forth any specific information as to when the agreement was made, the terms of the agreement upon which liability is predicated, or any other evidence supporting the formation of an agreement."). Indeed while the Complaint refers to a single "Agreement," in the opposition papers, Ostrolenk instead states that "[e]ach new patent and each new matter requested by Unigene constituted, at minimum, an implied contract." Opp. 4. Although the allegations in the Complaint suggest that some sort of contract existed between Unigene and Ostrolenk, particularly because I cannot imagine a reason that Ostrolenk would otherwise have submitted patent applications for Unigene over a period of more than 25 years, the breach of contract claim must nonetheless be dismissed.
My rules provide that if a party fails to amend in response to a motion to dismiss, no further opportunities to amend will be granted. Individual Practices 5.G. Presumably if Ostrolenk had been able to remedy the deficiencies in its breach of contract claim, it would have done so. Nevertheless and in accordance with FRCP 15(a)(2), which provides that leave to amend should be "granted freely . . . when justice so requires," Plaintiff will have 20 days from the date of this Order to amend, despite a variety of other claims for account stated, quantum meruit, and unjust enrichment. *fn2
C. The Demand for Attorneys' Fees is Dismissed
The Complaint demands judgment for "an award against Unigene for the value of the attorneys' fees, costs and disbursements incurred by Ostrolenk in connection with the litigation of the claims in this Complaint." Compl., Ad Damnum Clause E. Under New York Law, which follows the American Rule regarding attorneys' fees, "it is well established that attorneys' fees are not ordinarily recoverable in the absence of a statute or enforceable contract providing therefor."*fn3 Singer v. Xipto Inc., 10 Civ. 8501, 2012 WL 1071274, at * 8 (S.D.N.Y. Mar. 30, 2012) (quoting Summit Valley Indus., Inc. v. Local 112 United Bhd. of Carpenters & Joiners, 456 U.S. 717, 721 (1982)). Although Ostrolenk asserts that "[t]his issue is premature and not relevant to the Court's ruling on the motion and need not be briefed at this time," Opp. 5 n.1, courts have dismissed similar claims at this stage. See, e.g., Singer, 2012 WL 1071274, at *8 . (dismissing claim for attorneys' fees without prejudice where plaintiffs ...